Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Share-based Compensation (2020 - 2026)

Definitive Healthcare filings provide 6 years of Share-based Compensation readings, the most recent being $8.2 million for Q4 2025.

  • On a quarterly basis, Share-based Compensation rose 10.81% to $8.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $29.1 million, a 23.48% decrease, with the full-year FY2025 number at $29.1 million, down 23.48% from a year prior.
  • Share-based Compensation hit $8.2 million in Q4 2025 for Definitive Healthcare, up from $6.7 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $15.6 million in Q1 2024 to a low of $406000.0 in Q1 2021.
  • Median Share-based Compensation over the past 5 years was $7.8 million (2024), compared with a mean of $8.1 million.
  • Biggest five-year swings in Share-based Compensation: skyrocketed 1592.61% in 2022 and later tumbled 53.03% in 2025.
  • Definitive Healthcare's Share-based Compensation stood at $5.6 million in 2021, then soared by 103.31% to $11.4 million in 2022, then grew by 16.02% to $13.3 million in 2023, then plummeted by 44.43% to $7.4 million in 2024, then rose by 10.81% to $8.2 million in 2025.
  • The last three reported values for Share-based Compensation were $8.2 million (Q4 2025), $6.7 million (Q3 2025), and $7.0 million (Q2 2025) per Business Quant data.